High-grade endometrial stroma sarcomas show a strong and diffuse cyclin D1 positivity, are usually negative for CD10 and hormone receptors as well as melanocytic markers, and harbor the YWHAE–FAM22 genetic fusion in most cases [15, 16]. This evidence concerns the gene CCND1 and sarcoma.